SynDevRx News
Most Popular SynDevRx Story
20-year-old project delivers cancer breakthrough
About 20 years ago, Harvard researcher Donald Ingber accidentally stumbled on a mold that demonstrated a remarkable ability to prevent the growth of small blood vessels. That fungus went on to become... Read more...
Latest Headlines
- July 1, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
